Industry Research Reports

Home > Reports > Medical Care > Metagenomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Metagenomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 106 Pages

Report ld: 2333635

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Metagenomics is the study of genetic material recovered directly from environmental samples.

The global market for Metagenomics was estimated to be worth US$ 204.2 million in 2023 and is forecast to a readjusted size of US$ 397.8 million by 2030 with a CAGR of 9.5% during the forecast period 2024-2030

Metagenomics Market Size

M= millions and B=billions

North American market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Metagenomics include F. Hoffmann-La Roche, PerkinElmer, Thermo Fisher Scientific, The MITRE Corporation, Quest Diagnostics, Agilent Technologies, Aperiomics, Promega and Oxford Nanopore, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Metagenomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metagenomics by region & country, by Type, and by Application.

The Metagenomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomics.

Market Segmentation

Report Metric
Details
Report Title
Metagenomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 397.8 million
CAGR(2024-2030)
9.5%
Market Size Available for Years
2019-2030
Global Metagenomics Companies Covered
F. Hoffmann-La Roche, PerkinElmer, Thermo Fisher Scientific, The MITRE Corporation, Quest Diagnostics, Agilent Technologies, Aperiomics, Promega, Oxford Nanopore, Enterome SA, Swift Biosciences
Global Metagenomics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metagenomics Market, Segment by Type
Sequencing

Bioinformatics
Global Metagenomics Market, Segment by Application
Infectious Disease Diagnosis

Environmental Remediation

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metagenomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metagenomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metagenomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Metagenomics Product Introduction
    1.2 Global Metagenomics Market Size Forecast
    1.3 Metagenomics Market Trends & Drivers
        1.3.1 Metagenomics Industry Trends
        1.3.2 Metagenomics Market Drivers & Opportunity
        1.3.3 Metagenomics Market Challenges
        1.3.4 Metagenomics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Metagenomics Players Revenue Ranking (2023)
    2.2 Global Metagenomics Revenue by Company (2019-2024)
    2.3 Key Companies Metagenomics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Metagenomics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Metagenomics
    2.6 Metagenomics Market Competitive Analysis
        2.6.1 Metagenomics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Metagenomics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Sequencing
        3.1.2 Bioinformatics
    3.2 Global Metagenomics Sales Value by Type
        3.2.1 Global Metagenomics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Metagenomics Sales Value, by Type (2019-2030)
        3.2.3 Global Metagenomics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Infectious Disease Diagnosis
        4.1.2 Environmental Remediation
        4.1.3 Others
    4.2 Global Metagenomics Sales Value by Application
        4.2.1 Global Metagenomics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Metagenomics Sales Value, by Application (2019-2030)
        4.2.3 Global Metagenomics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Metagenomics Sales Value by Region
        5.1.1 Global Metagenomics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Metagenomics Sales Value by Region (2019-2024)
        5.1.3 Global Metagenomics Sales Value by Region (2025-2030)
        5.1.4 Global Metagenomics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Metagenomics Sales Value, 2019-2030
        5.2.2 North America Metagenomics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Metagenomics Sales Value, 2019-2030
        5.3.2 Europe Metagenomics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Metagenomics Sales Value, 2019-2030
        5.4.2 Asia Pacific Metagenomics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Metagenomics Sales Value, 2019-2030
        5.5.2 South America Metagenomics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Metagenomics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Metagenomics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Metagenomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Metagenomics Sales Value
    6.3 United States
        6.3.1 United States Metagenomics Sales Value, 2019-2030
        6.3.2 United States Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Metagenomics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Metagenomics Sales Value, 2019-2030
        6.4.2 Europe Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Metagenomics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Metagenomics Sales Value, 2019-2030
        6.5.2 China Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Metagenomics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Metagenomics Sales Value, 2019-2030
        6.6.2 Japan Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Metagenomics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Metagenomics Sales Value, 2019-2030
        6.7.2 South Korea Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Metagenomics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Metagenomics Sales Value, 2019-2030
        6.8.2 Southeast Asia Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Metagenomics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Metagenomics Sales Value, 2019-2030
        6.9.2 India Metagenomics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Metagenomics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 F. Hoffmann-La Roche
        7.1.1 F. Hoffmann-La Roche Profile
        7.1.2 F. Hoffmann-La Roche Main Business
        7.1.3 F. Hoffmann-La Roche Metagenomics Products, Services and Solutions
        7.1.4 F. Hoffmann-La Roche Metagenomics Revenue (US$ Million) & (2019-2024)
        7.1.5 F. Hoffmann-La Roche Recent Developments
    7.2 PerkinElmer
        7.2.1 PerkinElmer Profile
        7.2.2 PerkinElmer Main Business
        7.2.3 PerkinElmer Metagenomics Products, Services and Solutions
        7.2.4 PerkinElmer Metagenomics Revenue (US$ Million) & (2019-2024)
        7.2.5 PerkinElmer Recent Developments
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Profile
        7.3.2 Thermo Fisher Scientific Main Business
        7.3.3 Thermo Fisher Scientific Metagenomics Products, Services and Solutions
        7.3.4 Thermo Fisher Scientific Metagenomics Revenue (US$ Million) & (2019-2024)
        7.3.5 The MITRE Corporation Recent Developments
    7.4 The MITRE Corporation
        7.4.1 The MITRE Corporation Profile
        7.4.2 The MITRE Corporation Main Business
        7.4.3 The MITRE Corporation Metagenomics Products, Services and Solutions
        7.4.4 The MITRE Corporation Metagenomics Revenue (US$ Million) & (2019-2024)
        7.4.5 The MITRE Corporation Recent Developments
    7.5 Quest Diagnostics
        7.5.1 Quest Diagnostics Profile
        7.5.2 Quest Diagnostics Main Business
        7.5.3 Quest Diagnostics Metagenomics Products, Services and Solutions
        7.5.4 Quest Diagnostics Metagenomics Revenue (US$ Million) & (2019-2024)
        7.5.5 Quest Diagnostics Recent Developments
    7.6 Agilent Technologies
        7.6.1 Agilent Technologies Profile
        7.6.2 Agilent Technologies Main Business
        7.6.3 Agilent Technologies Metagenomics Products, Services and Solutions
        7.6.4 Agilent Technologies Metagenomics Revenue (US$ Million) & (2019-2024)
        7.6.5 Agilent Technologies Recent Developments
    7.7 Aperiomics
        7.7.1 Aperiomics Profile
        7.7.2 Aperiomics Main Business
        7.7.3 Aperiomics Metagenomics Products, Services and Solutions
        7.7.4 Aperiomics Metagenomics Revenue (US$ Million) & (2019-2024)
        7.7.5 Aperiomics Recent Developments
    7.8 Promega
        7.8.1 Promega Profile
        7.8.2 Promega Main Business
        7.8.3 Promega Metagenomics Products, Services and Solutions
        7.8.4 Promega Metagenomics Revenue (US$ Million) & (2019-2024)
        7.8.5 Promega Recent Developments
    7.9 Oxford Nanopore
        7.9.1 Oxford Nanopore Profile
        7.9.2 Oxford Nanopore Main Business
        7.9.3 Oxford Nanopore Metagenomics Products, Services and Solutions
        7.9.4 Oxford Nanopore Metagenomics Revenue (US$ Million) & (2019-2024)
        7.9.5 Oxford Nanopore Recent Developments
    7.10 Enterome SA
        7.10.1 Enterome SA Profile
        7.10.2 Enterome SA Main Business
        7.10.3 Enterome SA Metagenomics Products, Services and Solutions
        7.10.4 Enterome SA Metagenomics Revenue (US$ Million) & (2019-2024)
        7.10.5 Enterome SA Recent Developments
    7.11 Swift Biosciences
        7.11.1 Swift Biosciences Profile
        7.11.2 Swift Biosciences Main Business
        7.11.3 Swift Biosciences Metagenomics Products, Services and Solutions
        7.11.4 Swift Biosciences Metagenomics Revenue (US$ Million) & (2019-2024)
        7.11.5 Swift Biosciences Recent Developments

 8 Industry Chain Analysis
    8.1 Metagenomics Industrial Chain
    8.2 Metagenomics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Metagenomics Sales Model
        8.5.2 Sales Channel
        8.5.3 Metagenomics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Metagenomics Market Trends
    Table 2. Metagenomics Market Drivers & Opportunity
    Table 3. Metagenomics Market Challenges
    Table 4. Metagenomics Market Restraints
    Table 5. Global Metagenomics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Metagenomics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Metagenomics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Metagenomics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Metagenomics
    Table 10. Global Metagenomics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Metagenomics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Metagenomics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Metagenomics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Metagenomics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Metagenomics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Metagenomics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Metagenomics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Metagenomics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Metagenomics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Metagenomics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Metagenomics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Metagenomics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Metagenomics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Metagenomics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Metagenomics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Metagenomics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Metagenomics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Metagenomics Sales Value, (2025-2030) & (US$ Million)
    Table 31. F. Hoffmann-La Roche Basic Information List
    Table 32. F. Hoffmann-La Roche Description and Business Overview
    Table 33. F. Hoffmann-La Roche Metagenomics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Metagenomics Business of F. Hoffmann-La Roche (2019-2024)
    Table 35. F. Hoffmann-La Roche Recent Developments
    Table 36. PerkinElmer Basic Information List
    Table 37. PerkinElmer Description and Business Overview
    Table 38. PerkinElmer Metagenomics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Metagenomics Business of PerkinElmer (2019-2024)
    Table 40. PerkinElmer Recent Developments
    Table 41. Thermo Fisher Scientific Basic Information List
    Table 42. Thermo Fisher Scientific Description and Business Overview
    Table 43. Thermo Fisher Scientific Metagenomics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Metagenomics Business of Thermo Fisher Scientific (2019-2024)
    Table 45. Thermo Fisher Scientific Recent Developments
    Table 46. The MITRE Corporation Basic Information List
    Table 47. The MITRE Corporation Description and Business Overview
    Table 48. The MITRE Corporation Metagenomics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Metagenomics Business of The MITRE Corporation (2019-2024)
    Table 50. The MITRE Corporation Recent Developments
    Table 51. Quest Diagnostics Basic Information List
    Table 52. Quest Diagnostics Description and Business Overview
    Table 53. Quest Diagnostics Metagenomics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Metagenomics Business of Quest Diagnostics (2019-2024)
    Table 55. Quest Diagnostics Recent Developments
    Table 56. Agilent Technologies Basic Information List
    Table 57. Agilent Technologies Description and Business Overview
    Table 58. Agilent Technologies Metagenomics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Metagenomics Business of Agilent Technologies (2019-2024)
    Table 60. Agilent Technologies Recent Developments
    Table 61. Aperiomics Basic Information List
    Table 62. Aperiomics Description and Business Overview
    Table 63. Aperiomics Metagenomics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Metagenomics Business of Aperiomics (2019-2024)
    Table 65. Aperiomics Recent Developments
    Table 66. Promega Basic Information List
    Table 67. Promega Description and Business Overview
    Table 68. Promega Metagenomics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Metagenomics Business of Promega (2019-2024)
    Table 70. Promega Recent Developments
    Table 71. Oxford Nanopore Basic Information List
    Table 72. Oxford Nanopore Description and Business Overview
    Table 73. Oxford Nanopore Metagenomics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Metagenomics Business of Oxford Nanopore (2019-2024)
    Table 75. Oxford Nanopore Recent Developments
    Table 76. Enterome SA Basic Information List
    Table 77. Enterome SA Description and Business Overview
    Table 78. Enterome SA Metagenomics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Metagenomics Business of Enterome SA (2019-2024)
    Table 80. Enterome SA Recent Developments
    Table 81. Swift Biosciences Basic Information List
    Table 82. Swift Biosciences Description and Business Overview
    Table 83. Swift Biosciences Metagenomics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Metagenomics Business of Swift Biosciences (2019-2024)
    Table 85. Swift Biosciences Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Metagenomics Downstream Customers
    Table 89. Metagenomics Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Metagenomics Product Picture
    Figure 2. Global Metagenomics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Metagenomics Report Years Considered
    Figure 5. Global Metagenomics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Metagenomics Revenue in 2023
    Figure 7. Metagenomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Sequencing Picture
    Figure 9. Bioinformatics Picture
    Figure 10. Global Metagenomics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Metagenomics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Infectious Disease Diagnosis
    Figure 13. Product Picture of Environmental Remediation
    Figure 14. Product Picture of Others
    Figure 15. Global Metagenomics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Metagenomics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Metagenomics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Metagenomics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Metagenomics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Metagenomics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Metagenomics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Metagenomics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Metagenomics Sales Value (%), (2019-2030)
    Figure 28. United States Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Metagenomics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Metagenomics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Metagenomics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Metagenomics Industrial Chain
    Figure 50. Metagenomics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

Metagenomics is the study of genetic material recovered directly from environmental samples.

The global market for Metagenomics was estimated to be worth US$ 204.2 million in 2023 and is forecast to a readjusted size of US$ 397.8 million by 2030 with a CAGR of 9.5% during the forecast period 2024-2030

North American market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Metagenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation